The Development of a Domestic Violence Perpetrator Collusion Measurement Tool
NCT ID: NCT01942616
Last Updated: 2023-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2009-07-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Media to Shift Social Norms of Violence Among Youth
NCT02706145
Impact of Family-Centered Care for Intimate Partner Violence (IPV)
NCT06071299
Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative
NCT02021838
Fatherhood Focused Family Violence Education Program
NCT03883932
Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners
NCT00153452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.
Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.
Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.
Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.
Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Condition 1
Each study arm contains different scenarios presented to the participant.
Condition 1 is a Perpetrator Positive scenario.
The content of the Condition 1 group is as follows:
Framing: Episodic Labeling: DV label Extraneous Information: Perpetrator positive non relevant Victim/Perp Characteristic: Negative victim
Condition 1: Perpetrator Positive
Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.
Condition 2
Each study arm contains different scenarios presented to the participant.
Condition 2 is a Perpetrator Negative scenario.
The content of the Condition 2 group is as follows:
Framing: Thematic Labeling: Assault label Extraneous Information: Perpetrator neutral non relevant Victim/Perp Characteristic: Negative Perpetrator
Condition 2: Perpetrator Negative
The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.
Condition 3
Each study arm contains different scenarios presented to the participant.
The content of the Condition 3 group is as follows:
Framing: Neither Labeling: No label Extraneous Information: None Victim/Perp Characteristic: None
Condition 3: Placebo
This intervention provides no details for the participant and is for comparison use in the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Condition 1: Perpetrator Positive
Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.
Condition 2: Perpetrator Negative
The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.
Condition 3: Placebo
This intervention provides no details for the participant and is for comparison use in the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University
New Haven, Connecticut, United States
Loyola University New Orleans
New Orleans, Louisiana, United States
Michigan State University
East Lansing, Michigan, United States
Michigan Department of Community Health
Lansing, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0910005885
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.